Dr. Trevor Mundel, president of the Global Health Division, leads the foundation’s efforts in research and development of vaccines, drugs, and diagnostics to address major global health challenges in the developing world. Trevor oversees the foundation’s strategies in HIV, tuberculosis, malaria, pneumonia, diarrheal disease, enteric and diarrheal diseases, and neglected infectious diseases.
Under Trevor’s leadership, the Global Health Division also works on platform technologies to accelerate development of global health solutions. All of this work occurs in collaboration with an international network of grantees and partners.
Prior to joining the foundation in 2011, he was global head of development with Novartis, and previously was involved in clinical research at Pfizer and Parke-Davis.
A native of South Africa, Trevor earned his bachelor’s and medical degrees from the University of the Witwatersrand in Johannesburg. Trevor also studied mathematics, logic and philosophy – as a Rhodes Scholar – at the University of Oxford. And he earned a Ph.D. in mathematics at the University of Chicago.